Drug Makers Seek Clarity On IRA Issues At Monday Meeting With CMS

By Gabrielle Wanneh / February 27, 2023 at 4:48 PM
Drug industry representatives want more specifics on CMS’ timeline and process for considering feedback and proposing guidance to implement Medicare’s new drug price negotiation authority, and they hope CMS will flesh those specifics out during discussions with the industry Monday afternoon. CMS and drug companies are meeting Monday (Feb. 27) to discuss initial guidance the agency released this month on its implementation of the Inflation Reduction Act’s Part B and D inflation rebate provisions, which require drug companies pay Medicare...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.